Viva Biotech (1873.HK) Announces 2023 Interim Results: Solid

/PRNewswire/ -- On August 29, 2023, Viva Biotech Holdings Group ("Viva Biotech", "the Group" or "the Company", stock code: 1873.HK) announced that during the...

Related Keywords

United States , Suzhou , Jiangsu , China , Switzerland , Shanghai , Japan , Zhoupu , Zhejiang , Canada , Chengdu , Sichuan , France , United Kingdom , Qiantang , Guangdong , Germany , Australia , Taiwan , Hangzhou , America , Langhua Pharma , Cheney Mao , Successful Exit Of Incubation Portfolio Companies , Our Computational Chemistry Department , Shanghai Supercomputing Center , Viva Biotech Holdings , Viva Biotech Holdings Group , Temasek , Interim Results , Reporting Period , Highlight Capital , Increasing Number , Langhua Pharmaceutical , Viva Biotech , Investment Income , Successful Exit , Incubation Portfolio Companies , Will Continue , Incubation Business Through , Investment Funds , North America , Computational Chemistry Department , Faladi Road , Qiantang New District , Supercomputing Center , Chief Executive Officer , Health Care Amp Hospitals , Biotechnology , Medical Pharmaceuticals , Pharmaceuticals , Earnings , Sales Reports ,